Table 3.

Associations of patient, clinical, and tumor, and treatment-related characteristics with death from breast cancer within 5 years of diagnosis, for 30 deaths among 482 ER/PR positive breast cancer patients.

	N	BC Death %	P-Value
Race			<0.0001
White	264	2
Black	218	11
Age at diagnosis
<50	136	6
50–59	146	8
60–79	200	5
Education			0.08
<12	45	9
12	97	10
>12	338	5
Income			0.13
<20,000	96	9
<75,000	217	6
>75,000	156	4
Concentrated affluence			0.06
<1 SD below mean	26	8
Within 1 SD of mean	332	8
>1 SD above mean	124	2
Concentrated disadvantage			0.08
<1 SD below mean	91	2
Within 1 SD of mean	295	7
>1 SD above mean	96	8
Family History Breast Cancer
None	360	6
Weak	83	10
Strong	33	3
Parity			0.02
Parous	354	8
Nulliparous	128	2
Body Mass Index			0.07
Normal	166	5
Over	136	9
Obese	177	10
Insurance			0.07
None	36	14
Public	70	7
Private	376	5
Last clinical exam			0.003
Within two years	371	4
Longer/never	111	13
Mode of detection			<0.0001
Screening	270	1
Symptoms	212	12
Tumor grade			0.002
Low	114	3
Moderate	204	4
High	142	11
Stage at diagnosis			<0.0001
0 (in-situ)	297	1
1	130	9
2–4	48	25
Radiation			0.01
Not recommended	113	5
Recommended1	79	16
Initiated2	290	7
Chemotherapy			<0.001
Not recommended	249	3
Recommended1	39	10
Initiated2	194	14
Hormone Therapy			0.15
Not recommended	72	14
Recommended1	151	7
Initiated2	259	7

P-values >0.2 are suppressed